Vestcor Inc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 305 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vestcor Inc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$603
-3.1%
7,2910.0%0.02%
-4.8%
Q1 2024$622
-24.5%
7,291
-24.3%
0.02%
-25.0%
Q4 2023$824
-4.5%
9,6340.0%0.03%
-12.5%
Q3 2023$863
+73.3%
9,634
+64.5%
0.03%
+77.8%
Q2 2023$498
+2.7%
5,8550.0%0.02%0.0%
Q1 2023$485
-99.9%
5,855
+22.1%
0.02%
-33.3%
Q1 2020$478,000
-21.9%
4,797
-10.0%
0.03%
-6.9%
Q4 2019$612,0005,3300.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders